Austin Health

Title
A minimal role for synonymous variation in human disease.
Publication Date
2022-12-01
Author(s)
Dhindsa, Ryan S
Wang, Quanli
Vitsios, Dimitrios
Burren, Oliver S
Hu, Fengyuan
DiCarlo, James E
Kruglyak, Leonid
MacArthur, Daniel G
Hurles, Matthew E
Petrovski, Slavé
Subject
synonymous variation
Type of document
Journal Article
OrcId
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
DOI
10.1016/j.ajhg.2022.10.016
Abstract
Synonymous mutations change the DNA sequence of a gene without affecting the amino acid sequence of the encoded protein. Although some synonymous mutations can affect RNA splicing, translational efficiency, and mRNA stability, studies in human genetics, mutagenesis screens, and other experiments and evolutionary analyses have repeatedly shown that most synonymous variants are neutral or only weakly deleterious, with some notable exceptions. Based on a recent study in yeast, there have been claims that synonymous mutations could be as important as nonsynonymous mutations in causing disease, assuming the yeast findings hold up and translate to humans. Here, we argue that there is insufficient evidence to overturn the large, coherent body of knowledge establishing the predominant neutrality of synonymous variants in the human genome.
Link
Citation
American Journal of Human Genetics 2022
Jornal Title
American Journal of Human Genetics
ISSN
1537-6605

Files:

NameSizeformatDescriptionLink